Hainan Huluwa Pharmaceutical Group announced that it has recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for propofol and tenofovir tablets. Propofol and tenofovir tablets are used to treat chronic hepatitis B in adults and adolescents (aged 12 and above, weighing at least 35kg).
葫芦娃：获得富马酸丙酚替诺福韦片药品注册证书
Hainan Huluwa Pharmaceutical Group: obtained the pharmaceutical registration certificate for propofol and tenofovir tablets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.